Pfiz­er makes an­oth­er bil­lion-dol­lar in­vest­ment in Eu­rope and ex­pands again in Michi­gan

Pfiz­er is con­tin­u­ing its run of man­u­fac­tur­ing site ex­pan­sions with two new large in­vest­ments in the US and Eu­rope.

The New York-based phar­ma gi­ant’s site in Kala­ma­zoo, MI, has seen a lot of at­ten­tion over the past year. As a ma­jor piece of the man­u­fac­tur­ing net­work for Covid-19 vac­cines and an­tivi­rals, Pfiz­er is gear­ing up to place more mon­ey in­to the site. Pfiz­er an­nounced it will place $750 mil­lion in­to the fa­cil­i­ty, main­ly to es­tab­lish “mod­u­lar asep­tic pro­cess­ing” (MAP) pro­duc­tion and cre­ate around 300 jobs at the site.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER